Myricetin bioactive effects: moving from preclinical evidence to potential clinical applications

Autor: Elena Azzini, Javad Sharifi-Rad, Ahmet Beyatli, Yasaman Taheri, Hafiz Ansar Rasul Suleria, William N. Setzer, Anuj Kumar, Alfred Maroyi, Prabhakar Semwal, Miquel Martorell, G. A. Seitimova, Sakshi Painuli, Oksana Sytar, Balakyz Yeskaliyeva, Bahare Salehi, Natália Martins

Publikováno v: BMC Complementary Medicine and Therapies, Vol 20, Iss 1, Pp 1-14 (2020)
BMC Complementary Medicine and Therapies

Several flavonoids have been recognized as nutraceuticals, and myricetin is a good example. Myricetin is commonly found in plants and their antimicrobial and antioxidant activities is well demonstrated. One of its beneficial biological effects is the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c76e7770e1cb61be1b55d8533431a56
http://link.springer.com/article/10.1186/s12906-020-03033-z

A harmine-derived beta-carboline displays anti-cancer effects in vitro by targeting protein synthesis

Autor: Jennifer Chu, Annelise De Carvalho, Bernard Masereel, Robert Kiss, Céline Meinguet, Guy Vandenbussche, Johan Wouters, Véronique Mathieu, Alexander Kornienko, Jerry Pelletier

Publikováno v: Carvalho, A, Chu, J, Meinguet, C, Kiss, R, Vandenbussche, G, Masereel, B, Wouters, J, Kornienko, A, Pelletier, J & Mathieu, V 2017, ' A harmine-derived beta-carboline displays anti-cancer effects in vitro by targeting protein synthesis ', European Journal of Pharmacology, vol. 805, pp. 25-35 . https://doi.org/10.1016/j.ejphar.2017.03.034

Growing evidence indicates that protein synthesis is deregulated in cancer onset and progression and targeting this process might be a selective way to combat cancers. While harmine is known to inhibit DYRK1A and intercalate into the DNA, tri-substit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8222dd162259798b461077c3cdb9a71
https://doi.org/10.1016/j.ejphar.2017.03.034

Natural Products and Synthetic Analogs as a Source of Antitumor Drugs

Autor: Yasaman Taheri, Adem Ozleyen, Abdelaali Balahbib, Javad Sharifi-Rad, Tugba Boyunegmez Tumer, Abdelhakim Bouyahya, Miquel Martorell, William C. Cho, Nasreddine El Omari, Natália Martins, Charles Oluwaseun Adetunji

Publikováno v: Biomolecules
Biomolecules, Vol 9, Iss 11, p 679 (2019)

Cancer is a heterogeneous disease and one of the major issues of health concern, especially for the public health system globally. Nature is a source of anticancer drugs with abundant pool of diverse chemicals and pharmacologically active compounds.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45cbeda15014a8175817bd6467aed5c9
https://pubmed.ncbi.nlm.nih.gov/31683894

Enhanced surface plasmon resonance (SPR) signals based on immobilization of core-shell nanoparticles incorporated boron nitride nanosheets: Development of molecularly imprinted SPR nanosensor for anticancer drug, etoposide

Autor: Abdullah Özkan, Necip Atar, Mehmet Lütfi Yola

WOS: 000461526200030
30776616
An effective SPR nanosensor based on core-shell nanoparticles (Ag@AuNPs) incorporated hexagonal boron nitride (HBN) nanosheets and molecularly imprinted polymer (MIP) was presented for etoposide (ETO) detection

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9094ea1bda5024e92ec067ebd09dd2ed

Actual versus recommended storage temperatures of oral anticancer medicines at patients' homes

Autor: Vlieland, Nicolaas D, van den Bemt, B, van Riet-Nales, Diana A, Bouvy, M L, Egberts, Toine, Gardarsdottir, H, Pharmacoepidemiology and Clinical Pharmacology, Afd Pharmacoepi & Clinical Pharmacology

Publikováno v: Journal of Oncology Pharmacy Practice, 25, 382-389
Journal of Oncology Pharmacy Practice
Journal of Oncology Pharmacy Practice, 25(2), 382. SAGE Publications Ltd
Journal of Oncology Pharmacy Practice, 25, 2, pp. 382-389
Journal of Oncology Pharmacy Practice, 25(2), 382-389. SAGE Publications Inc.

Background Substantial quantities of unused medicines are returned by patients to the pharmacy each year. Redispensing these medicines would reduce medicinal waste and health care costs. However, it is not known if medicines are stored by patients as

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::965711db058d2d3dfc1a2f764244377c
http://hdl.handle.net/2066/201140